Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,949

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,732

Class I recallsReasonable probability of serious health consequences

24,263

Class II recallsTemporary or medically reversible health consequences

2,873

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,071 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/foods-alive-recalls-organic-moringa-leaf-powder-because-possible-health-riskPublished September 4, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 6, 2026 ET

Summary (Year to date)

1,458 recalls have been announced year to date.
Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,263
Class I	9,732
Class III	2,873
Not Yet Classified	1

Recalls by class
Class	Recalls
Class II	24,263
Class I	9,732
Class III	2,873
Not Yet Classified	1

FDA Recall Ongoing 2026 recordClass II

FHF Farmhouse Fresh, Midnight Clearing, NIGHT LOTION, 2.5% BENZOYL PEROXIDE ACNE TREATMENT, OTC a) 0.5 fl. oz./15ml; and b)1 fl. oz./30ml tubes; Made in the USA for FarmHouse Fresh, 8797 CR 858 McKinney, Texas

by Owen Biosciences Inc.

Reason: Chemical contamination: Presence of benzene
Published: April 22, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

by Cipla USA, Inc.

Reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Published: April 22, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-411-02

by Cipla USA, Inc.

Reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Published: April 22, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

by Cipla USA, Inc.

Reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Published: April 22, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.

by GE Healthcare Ireland Limited

Reason: Presence of particulate matter
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.

by GE Healthcare Ireland Limited

Reason: Presence of particulate matter
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91

by Viatris, Inc.

Reason: Failed Dissolution Specifications
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0

by Preferred Pharmaceuticals, Inc.

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01

by Fagron Compounding Services

Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01

by Fagron Compounding Services

Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01

by Fagron Compounding Services

Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02

by Fagron Compounding Services

Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02

by Fagron Compounding Services

Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by Fresenius Kabi, Unit of Sale NDC Number: 17271-701-07.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freeflex bag, 1,000 mLx10, Fresenius Medical Care, Waltham, MA 02451, Distributed by: Fresenius Medical Care RTG, LLC, Manufactured by: Fresenius Kabi, Unit of Use NDC: 65219-282-01, Unit of Sale NDC Number: 65219-282-10.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20, Unit of Sale NDC Number: 65219-432-85.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility
Published: April 15, 2026
Distribution: Nationwide

View recall →

Data last updated: September 6, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.